Generic Pharmaceuticals News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–10 of 10 articles
Supreme Court sides with generic drug maker in icosapent ethyl patent case
Generic Drugmakers Gain Key Victory in ‘Skinny Label’ Patent Case
Elite Pharma Files FDA ANDA for $26B Generic Blood Thinner, Targeting Key Anticoagulant Market
Accord Healthcare Relaunches Tadalafil Tablets in Multiple Dosage Strengths, Expanding Generic ED Treatment Access
Phathom Pharmaceuticals VOQUEZNA Sales Surge 104% in Q1 2026, Company Maintains Profitability Guidance
FDA Generic Drug User Fee Amendments (GDUFA) Program Updates Fee Structure and Payment Methods for 2024
FDA Begins Preparation for GDUFA IV Reauthorization: Generic Drug User Fee Program 2028-2032
Cipla Receives FDA Approval for First Generic Ventolin HFA (Albuterol Sulfate) - AB-Rated Therapeutic Equivalent
Corbus Pharmaceuticals CRB-913 Obesity Drug Completes Patient Enrollment in CANYON-1 Phase 1b Trial
Apotex Receives FDA Approval for First Generic Infuvite Adult Injection with 180-Day Exclusivity